
The tolerance of a zzso human zzso zzso zzso Hu zzso zzso zzso zzso and its zzso effectiveness in combination with zzso killer zzso cells was examined in 26 patients with zzso solid tumors, including 14 zzso cell zzso seven zzso three zzso germ cell tumors zzso to chemotherapy and two colon zzso zzso was administered as a zzso at 30,000 zzso every 8 h on days zzso and days zzso zzso was done on days zzso zzso were incubated with zzso for 3 or 4 days in zzso and zzso on days 12, 13 and zzso The mean number of zzso cells was zzso zzso zzso per zzso zzso dose and schedule were adjusted according to zzso Patients received a median of zzso zzso zzso of planned zzso on days zzso and a median of zzso zzso zzso on days zzso zzso leak syndrome with zzso and impaired zzso function and zzso toxicity were the major reasons for dose zzso Patients with zzso cell zzso most of whom underwent a prior zzso had a reduced tolerance to zzso zzso responses were documented in three zzso cell zzso and one zzso The median response duration was zzso zzso zzso zzso 

